Cargando…

Ocular development after highly effective modulator treatment early in life

Highly effective cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulator therapies (HEMT), including elexacaftor-tezacaftor-ivacaftor, correct the underlying molecular defect causing CF. HEMT decreases general symptom burden by improving clinical metrics and quality of life for mos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yimin, Li, Danni, Reyes-Ortega, Felisa, Chinnery, Holly R., Schneider-Futschik, Elena K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547496/ https://www.ncbi.nlm.nih.gov/pubmed/37795027 http://dx.doi.org/10.3389/fphar.2023.1265138

Ejemplares similares

Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
por: Schneider-Futschik, Elena K., et al.
Publicado: (2021)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
por: Han, Xiaoxuan, et al.
Publicado: (2023)

Editorial: Women in pharmacology of infectious diseases: 2021
por: Schneider-Futschik, Elena K., et al.
Publicado: (2022)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
por: Li, Danni, et al.
Publicado: (2023)

Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain
por: Toguri, James T., et al.
Publicado: (2016)

Outcome Measures Used in Ocular Gene Therapy Trials: A Scoping Review of Current Practice
por: Jolly, Jasleen K., et al.
Publicado: (2019)

Tunneling Nanotubes and the Eye: Intercellular Communication and Implications for Ocular Health and Disease
por: Chinnery, Holly R., et al.
Publicado: (2020)

Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Rapamycin Attenuates High Glucose-Induced Inflammation Through Modulation of mTOR/NF-κB Pathways in Macrophages
por: Dai, Jiezhi, et al.
Publicado: (2019)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies
por: Reyes-Ortega, Felisa, et al.
Publicado: (2021)

Theissenolactone C Exhibited Ocular Protection of Endotoxin-Induced Uveitis by Attenuating Ocular Inflammatory Responses and Glial Activation
por: Lin, Fan-Li, et al.
Publicado: (2018)

Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation
por: Yang, Qiwei, et al.
Publicado: (2016)

Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023)

Topical Medication Therapy for Glaucoma and Ocular Hypertension
por: Wang, Tao, et al.
Publicado: (2021)

Ocular drug delivery: a clue from nanotechnology
por: Bucolo, Claudio, et al.
Publicado: (2012)

Gabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies
por: Anfuso, Carmelina D., et al.
Publicado: (2017)

The Primary Cilium as a Therapeutic Target in Ocular Diseases
por: Zhou, Peng, et al.
Publicado: (2020)

Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease
por: Bucolo, Claudio, et al.
Publicado: (2019)

Effects of Topical Gabapentin on Ocular Pain and Tear Secretion
por: Cammalleri, Maurizio, et al.
Publicado: (2021)

Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022)

Proton Sensing on the Ocular Surface: Implications in Eye Pain
por: Comes, Núria, et al.
Publicado: (2021)

Endocannabinoid Modulation of Dopaminergic Motor Circuits
por: Morera-Herreras, Teresa, et al.
Publicado: (2012)

Acidic Mammalian Chitinase and the Eye: Implications for Ocular Inflammatory Diseases
por: Bucolo, Claudio, et al.
Publicado: (2011)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
por: Park, Bomina, et al.
Publicado: (2019)

Therapeutic Effects of Melatonin on Ocular Diseases: Knowledge Map and Perspective
por: Yu, Haozhe, et al.
Publicado: (2021)

Mechanisms of Peripheral and Central Pain Sensitization: Focus on Ocular Pain
por: Puja, Giulia, et al.
Publicado: (2021)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Si-Ni-San alleviates early life stress-induced depression-like behaviors in adolescence via modulating Rac1 activity and associated spine plasticity in the nucleus accumbens
por: Ye, Lihong, et al.
Publicado: (2023)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
por: Zhu, Yingying, et al.
Publicado: (2021)

Evaluating the Beneficial and Detrimental Effects of Bile Pigments in Early and Later Life
por: Dennery, Phyllis A.
Publicado: (2012)

Immune Challenges and Seizures: How Do Early Life Insults Influence Epileptogenesis?
por: Semple, Bridgette D., et al.
Publicado: (2020)

Postponement of the opacification of lentoid bodies derived from human induced pluripotent stem cells after lanosterol treatment—the first use of the lens aging model in vitro in cataract drug screening
por: Zhang, Lifang, et al.
Publicado: (2022)

Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
por: Sharif, Najam A.
Publicado: (2021)

Antibody Format and Serum Disposition Govern Ocular Pharmacokinetics of Intravenously Administered Protein Therapeutics
por: Shivva, Vittal, et al.
Publicado: (2021)

Magnetic Nanoparticles Coated with a Thermosensitive Polymer with Hyperthermia Properties
por: Reyes-Ortega, Felisa, et al.
Publicado: (2017)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
por: Zhang, Jun, et al.
Publicado: (2018)

Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice
por: Castany, Sílvia, et al.
Publicado: (2019)

Orthogonal Drug Pooling Enhances Phenotype-Based Discovery of Ocular Antiangiogenic Drugs in Zebrafish Larvae
por: Ohnesorge, Nils, et al.
Publicado: (2019)

Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
por: Fiedorowicz, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6gm5tdn1nbvmkbpphrbbe6r4s3